Serrawan 10mg Tablet

Tablet
Rs.47.30for 1 strip(s) (10 tablets each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Serrawan 10mg Tablet

Serratiopeptidase(10mg)

food interaction for Serrawan Tablet

alcohol interaction for Serrawan Tablet

pregnancy interaction for Serrawan Tablet

lactation interaction for Serrawan Tablet

food
alcohol
pregnancy
lactation
Serrawan 10mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
None
CAUTION
It is not known whether it is safe to consume alcohol with Serrawan 10mg Tablet. Please consult your doctor.
CONSULT YOUR DOCTOR
Information regarding the use of Serrawan 10mg Tablet during pregnancy is not available. Please consult your doctor.
CONSULT YOUR DOCTOR
Information regarding the use of Serrawan 10mg Tablet during breastfeeding is not available. Please consult your doctor.
CONSULT YOUR DOCTOR

SALT INFORMATION FOR Serrawan 10mg Tablet

Serratiopeptidase(10mg)

Serrawan tablet uses

{med_name} is used in the treatment of pain relief and swelling.

How serrawan tablet works

Serrawan 10mg Tablet is an enzyme that works by breaking down the chemical messengers involved in pain and inflammation (redness and swelling).

Common side effects of serrawan tablet

No common side effects seen

SUBSTITUTES FOR Serrawan Tablet

462 Substitutes
462 Substitutes
Sorted By
RelevancePrice

Expert advice FOR Serrawan Tablet

  • Serratiopeptidase helps relieve pain and swelling associated with post-operative wounds and inflammatory diseases.
  • Take it 30 minutes before a meal or as directed by your doctor.
  • Stop using Serratiopeptidase at least 2 weeks before a scheduled surgery as it may interfere with blood clotting.
  • Inform your doctor if you have liver or kidney disease or problems with your blood clotting mechanism.
  • Serratiopeptidase helps relieve pain and swelling associated with post-operative wounds and inflammatory diseases.
  • Take it 30 minutes before a meal or as directed by your doctor.
  • Stop using Serratiopeptidase at least 2 weeks before a scheduled surgery as it may interfere with blood clotting.
  • Inform your doctor if you have liver or kidney disease or problems with your blood clotting mechanism.

Frequently asked questions FOR Serrawan 10mg Tablet

Serratiopeptidase

Q. What is Serrawan 10mg Tablet used for?
Serrawan 10mg Tablet is an enzyme used to reduce inflammation and pain associated with conditions such as osteoarthritis, rheumatoid arthritis, back pain, sinusitis, and post-surgical swelling. It helps by breaking down proteins that cause swelling and supports healing.
Q. What precautions should I take before using Serrawan 10mg Tablet?
Before using Serrawan 10mg Tablet, inform your doctor if you have bleeding disorders, are on blood thinners, have liver or kidney disease, or if you are pregnant or breastfeeding. Stop using it at least two weeks before surgery, as it may affect blood clotting.
Q. Who should not take Serrawan 10mg Tablet?
Individuals should not take Serrawan 10mg Tablet if they are allergic to it, or have a history of bleeding disorders, severe kidney or liver problems. Also, this medicine is not recommended for children or if the person has active infections that could worsen due to its fibrinolytic effects (process of breaking down blood clots).
Show More
Q. Are there any serious side effects of Serrawan 10mg Tablet?
Although rare, serious side effects of Serrawan 10mg Tablet may include severe allergic reactions, chest tightness, breathing difficulty, or signs of infection spreading. Seek immediate medical attention if any of these symptoms occur.
Q. How long should I take Serrawan 10mg Tablet?
The duration of Serrawan 10mg Tablet treatment varies based on your medical condition and the doctor’s prescription. It can be used for 1 to 2 weeks for anti-inflammatory effects, and up to 4 weeks for more severe pain and swelling. Do not use longer than recommended.
Q. Is Serrawan 10mg Tablet addictive?
No, Serrawan 10mg Tablet is not addictive and does not lead to dependence.

Content on this page was last updated on 21 September, 2025, by Dr. Lalit Kanodia (MBA, MD Pharmacology)